Skip to main content
. 2015 Feb 28;6(8):6001–6013. doi: 10.18632/oncotarget.3469

Figure 5. Schematic representation of the method used for the analysis of Cir-ITCH regulated progress of ESCC.

Figure 5

Cir-ITCH is a potential tumor suppressor acting through the control of miRNAs activity such as miR-7, miR-17, miR-214 and increase the concentration of ITCH, resulting in suppression of the canonical Wnt pathway by degradation of phosphorylated Dvl2, and inhibited the oncogene c-myc expression therefore inhibit canonical Wnt signaling.